EDYTHE HARRIS LUCAS AND CLARA LUCAS LYNN CHAIR IN HEMATOLOGY
Established in 1992 by the estate of Clara Lucas Lynn
CLARA LUCAS LYNN of Poughkeepsie, New York, was a patient and friend of Hopkins physician William R. Bell. In making plans for this gift, Mrs. Lynn was primarily interested in supporting research into blood disorders and, in particular, providing continued support for Dr. Bell's research. This professorship also honors Mrs. Lynn's mother, EDYTHE HARRIS LUCAS. (The photograph shows Hopkins researchers at work.)
ROBERT A. BRODSKY, the Edythe Harris Lucas and Clara Lucas Lynn Professor of Hematology, joined the Hopkins faculty in 1997 and now directs the Division of Hematology as well as the Hematology Fellowship Training Program. Board certified in internal medicine, hematology, and oncology, Dr. Brodsky was named as a Clinical Research Scholar of the Leukemia and Lymphoma Society of America in 2000 and a Fellow of the American College of Physicians in 2004. His clinical and laboratory interests include bone marrow failure disorders and autoimmune diseases. He and his colleagues have pioneered the use of high dose cyclophosphamide therapy for the treatment of aplastic anemia and other autoimmune conditions. Dr. Brodsky has authored or co-authored nearly 50 scientific articles, and contributed book reviews and numerous book chapters and holds a patent for detection of GPI anchored proteins.
CLARA LUCAS LYNN of Poughkeepsie, New York, was a patient and friend of Hopkins physician William R. Bell. In making plans for this gift, Mrs. Lynn was primarily interested in supporting research into blood disorders and, in particular, providing continued support for Dr. Bell's research. This professorship also honors Mrs. Lynn's mother, EDYTHE HARRIS LUCAS. (The photograph shows Hopkins researchers at work.) 
ROBERT A. BRODSKY, the Edythe Harris Lucas and Clara Lucas Lynn Professor of Hematology, joined the Hopkins faculty in 1997 and now directs the Division of Hematology as well as the Hematology Fellowship Training Program. Board certified in internal medicine, hematology, and oncology, Dr. Brodsky was named as a Clinical Research Scholar of the Leukemia and Lymphoma Society of America in 2000 and a Fellow of the American College of Physicians in 2004. His clinical and laboratory interests include bone marrow failure disorders and autoimmune diseases. He and his colleagues have pioneered the use of high dose cyclophosphamide therapy for the treatment of aplastic anemia and other autoimmune conditions. Dr. Brodsky has authored or co-authored nearly 50 scientific articles, and contributed book reviews and numerous book chapters and holds a patent for detection of GPI anchored proteins.